JP2007252368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007252368A5 JP2007252368A5 JP2007040772A JP2007040772A JP2007252368A5 JP 2007252368 A5 JP2007252368 A5 JP 2007252368A5 JP 2007040772 A JP2007040772 A JP 2007040772A JP 2007040772 A JP2007040772 A JP 2007040772A JP 2007252368 A5 JP2007252368 A5 JP 2007252368A5
- Authority
- JP
- Japan
- Prior art keywords
- modification
- modified protein
- lysine
- protein according
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012986 modification Methods 0.000 claims 11
- 230000004048 modification Effects 0.000 claims 11
- 102000035118 modified proteins Human genes 0.000 claims 11
- 108091005573 modified proteins Proteins 0.000 claims 11
- 150000001413 amino acids Chemical class 0.000 claims 10
- 235000001014 amino acid Nutrition 0.000 claims 9
- 229940024606 amino acid Drugs 0.000 claims 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 8
- 239000004472 Lysine Substances 0.000 claims 8
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 4
- 235000003704 aspartic acid Nutrition 0.000 claims 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 4
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 3
- 239000004473 Threonine Substances 0.000 claims 3
- 235000004279 alanine Nutrition 0.000 claims 3
- 235000018102 proteins Nutrition 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 2
- 108060003951 Immunoglobulin Proteins 0.000 claims 2
- 238000001042 affinity chromatography Methods 0.000 claims 2
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 2
- 102000018358 immunoglobulin Human genes 0.000 claims 2
- 102000028557 immunoglobulin binding proteins Human genes 0.000 claims 2
- 108091009323 immunoglobulin binding proteins Proteins 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- KJBJPJYEPGYTJX-ZBRNBAAYSA-N (2s)-2-aminobutanedioic acid;(2s)-pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1.OC(=O)[C@@H](N)CC(O)=O KJBJPJYEPGYTJX-ZBRNBAAYSA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Chemical group OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical group CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical group CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Chemical group CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 235000009582 asparagine Nutrition 0.000 claims 1
- 229960001230 asparagine Drugs 0.000 claims 1
- 230000014509 gene expression Effects 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Chemical group 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Chemical group CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007040772A JP4179517B2 (ja) | 2006-02-21 | 2007-02-21 | イムノグロブリン親和性リガンド |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006043358 | 2006-02-21 | ||
| JP2007040772A JP4179517B2 (ja) | 2006-02-21 | 2007-02-21 | イムノグロブリン親和性リガンド |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008075647A Division JP2008214350A (ja) | 2006-02-21 | 2008-03-24 | イムノグロブリン親和性リガンド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007252368A JP2007252368A (ja) | 2007-10-04 |
| JP2007252368A5 true JP2007252368A5 (OSRAM) | 2007-12-27 |
| JP4179517B2 JP4179517B2 (ja) | 2008-11-12 |
Family
ID=38627234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007040772A Active JP4179517B2 (ja) | 2006-02-21 | 2007-02-21 | イムノグロブリン親和性リガンド |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4179517B2 (OSRAM) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10723769B2 (en) | 2015-03-26 | 2020-07-28 | Jsr Corporation | Immunoglobulin-binding protein and affinity carrier using same |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2006381B1 (en) | 2006-03-31 | 2016-02-03 | Chugai Seiyaku Kabushiki Kaisha | Method for controlling blood pharmacokinetics of antibodies |
| CA2700701C (en) | 2007-09-26 | 2020-12-29 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| NZ717429A (en) | 2008-04-11 | 2018-07-27 | Chugai Pharmaceutical Co Ltd | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
| SG195555A1 (en) | 2008-12-24 | 2013-12-30 | Emd Millipore Corp | Caustic stable chromatography ligands |
| EP2412809B1 (en) | 2009-03-24 | 2017-08-09 | Kaneka Corporation | Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand |
| WO2011118699A1 (ja) | 2010-03-24 | 2011-09-29 | 株式会社カネカ | 免疫グロブリンに特異的に結合するタンパク質および免疫グロブリン結合性アフィニティーリガンド |
| CN108715614A (zh) | 2010-11-30 | 2018-10-30 | 中外制药株式会社 | 与多分子的抗原重复结合的抗原结合分子 |
| JP5997176B2 (ja) | 2010-12-21 | 2016-09-28 | ザ ユニバーシティ オブ ウエスタン オンタリオＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ ｏｆ Ｗｅｓｔｅｒｎ Ｏｎｔａｒｉｏ | プロテインａの新規アルカリ抵抗性変異体及びアフィニティークロマトグラフィーにおけるその使用 |
| CN103270044B (zh) | 2010-12-21 | 2016-03-09 | Jsr株式会社 | 亲和色谱用载体和分离免疫球蛋白的方法 |
| JP6038774B2 (ja) | 2011-03-24 | 2016-12-07 | 株式会社カネカ | タンパク性物質結合性低分子化合物 |
| JPWO2012133349A1 (ja) | 2011-03-25 | 2014-07-28 | 株式会社カネカ | アフィニティー分離マトリックス用タンパク質 |
| CN104640983A (zh) | 2012-09-21 | 2015-05-20 | 株式会社钟化 | 亲和分离基质用蛋白质配体 |
| WO2015034000A1 (ja) * | 2013-09-04 | 2015-03-12 | プロテノバ株式会社 | イムノグロブリン結合ドメイン多量体 |
| JP6491600B2 (ja) | 2013-09-27 | 2019-03-27 | 株式会社カネカ | アルカリ水溶液を用いた多孔質セルロースビーズの製造方法 |
| KR102650420B1 (ko) | 2014-12-19 | 2024-03-21 | 추가이 세이야쿠 가부시키가이샤 | 항-마이오스타틴 항체, 변이체 Fc 영역을 함유하는 폴리펩타이드, 및 사용 방법 |
| JP6663360B2 (ja) | 2015-01-26 | 2020-03-11 | 株式会社カネカ | 変異型免疫グロブリンκ鎖可変領域結合性ペプチド |
| WO2016121701A1 (ja) | 2015-01-26 | 2016-08-04 | 株式会社カネカ | 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス |
| WO2017022672A1 (ja) * | 2015-07-31 | 2017-02-09 | 株式会社カネカ | 免疫グロブリン結合性改変型タンパク質 |
| EP3375873B1 (en) * | 2015-10-22 | 2025-07-02 | Protenova Co., Ltd. | Immunoglobulin-binding polypeptide |
| JP7141336B2 (ja) | 2015-12-25 | 2022-09-22 | 中外製薬株式会社 | 抗ミオスタチン抗体および使用方法 |
| WO2017195638A1 (ja) | 2016-05-09 | 2017-11-16 | 株式会社カネカ | 抗体またはκ鎖可変領域含有抗体断片の精製方法 |
| TW202300168A (zh) | 2016-08-05 | 2023-01-01 | 日商中外製藥股份有限公司 | Il-8相關疾病之治療用或預防用組成物 |
| CN112368302B (zh) * | 2018-06-29 | 2023-06-27 | 国立大学法人京都工艺纤维大学 | 分离剂 |
| WO2020004671A1 (ja) | 2018-06-29 | 2020-01-02 | 国立大学法人京都工芸繊維大学 | 分離剤 |
| US12428451B2 (en) | 2018-08-24 | 2025-09-30 | Jsr Corporation | Immunoglobulin-binding protein, and affinity carrier using same |
| WO2020189766A1 (ja) * | 2019-03-20 | 2020-09-24 | プロテノバ株式会社 | 抗体結合能を有するポリペプチド修飾リポソーム、及びイムノリポソーム |
| AU2020273072A1 (en) * | 2019-04-10 | 2021-12-09 | Chugai Seiyaku Kabushiki Kaisha | Method for purifying Fc region-modified antibody |
| JP7587200B2 (ja) * | 2020-08-19 | 2024-11-20 | 東ソー株式会社 | 免疫グロブリン結合性ポリペプチド |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006304633A (ja) * | 2005-04-26 | 2006-11-09 | Apro Life Science Institute Inc | イムノグロブリン結合タンパク質 |
-
2007
- 2007-02-21 JP JP2007040772A patent/JP4179517B2/ja active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10723769B2 (en) | 2015-03-26 | 2020-07-28 | Jsr Corporation | Immunoglobulin-binding protein and affinity carrier using same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007252368A5 (OSRAM) | ||
| US12486307B2 (en) | Caustic stable chromatography ligands | |
| US9868761B2 (en) | Buffer system for protein purification | |
| EP2157099B1 (en) | Novel immunoglobulin-binding proteins with improved specificity | |
| CN103890174B (zh) | IgG结合性肽及利用其检测和纯化IgG的方法 | |
| JP2024026255A5 (OSRAM) | ||
| JP2014528906A5 (OSRAM) | ||
| JP2014500311A5 (OSRAM) | ||
| JP2014510518A5 (OSRAM) | ||
| JPWO2020209318A5 (OSRAM) | ||
| US20150183820A1 (en) | Scavenger containing protein formed from tandem-type multimer of mutant extracellular domain of protein g | |
| US20140221613A1 (en) | Novel modified protein comprising tandem-type multimer of mutant extracellular domain of protein g | |
| JPWO2015050153A1 (ja) | 免疫グロブリンＧ（ＩｇＧ）のＦｃ部分を有するタンパク質に対するアフィニティを有する複数のドメイン間をリンカーで結合させて成るタンパク質 | |
| JPWO2019147973A5 (OSRAM) | ||
| JP2015019615A (ja) | プロテインｇの細胞膜外ドメイン変異体の新規な改変型タンパク質 | |
| JP2015003872A (ja) | マウスＩｇＧの精製方法 | |
| Subramanian et al. | Use of modified chitosan macrospheres in the selective removal of immunoglobulins | |
| WO2015190439A1 (ja) | 抗体に結合する低分子化合物のスクリーニング方法 | |
| WO2015093507A1 (ja) | プロテインｇの細胞膜外ドメインの新規な改変型タンパク質 | |
| JP2016024087A (ja) | 脱塩された糖ペプチド含有ペプチド試料を調製する方法 |